Short answer
Praxis Precision Medicines, Inc. (PRAX) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 2026 results announced for quarter ended March 31, 2026.
Praxis Precision Medicines, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results announced for quarter ended March 31, 2026
- Financial details and management commentary contained in furnished Exhibit 99.1
- Filing represents an earnings update requiring review of the exhibit for investor-relevant figures
Item 7.01 · Regulation FD Disclosure
- Updated corporate presentation dated May 7, 2026, targeting investors, analysts and other stakeholders
- Presentation available on Praxis’s investor website and furnished as Exhibit 99.2
- Reg FD disclosure is furnished, not filed, limiting Section 18 liability and automatic incorporation into other filings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Praxis Precision Medicines, Inc. 8-K filings
Get the next PRAX 8-K as it lands
Follow PRAX for push alerts, or ask the research agent what this filing means.